Event Type
Disclosure
Mandatory
Variant
8-K
. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 20, 2025, Protagenic Therapeutics, Inc. (the
of this Current Report, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated November 26, 2025, furnished herewith. 104 Cover Page Inter